Allara is a technology company.
Allara is a telehealth care program that specializes in treating complex hormonal, metabolic, and gynecological conditions, providing personalized treatment plans and ongoing support.
Allara has raised $36.0M across 2 funding rounds.
Allara has raised $36.0M in total across 2 funding rounds.
Allara has raised $36.0M in total across 2 funding rounds.
Allara's investors include Addition, Forerunner Ventures, Future Positive Capital, David Krane, GV, Hardware Club, Index Ventures, Proximo Ventures, #SecretFund, True Ventures, Clement Benoit, Fanny Surjana.
Allara is a New York-based telehealth technology company specializing in comprehensive care for women with complex hormonal, metabolic, and gynecological conditions such as polycystic ovary syndrome (PCOS), endometriosis, insulin resistance, and related disorders. It offers a membership-based platform that connects patients with board-certified medical providers, including OB-GYNs, endocrinologists, and registered dietitians, delivering virtual appointments, testing, medication management, and lifestyle support. Allara addresses the fragmented and often inadequate care landscape for these chronic conditions by providing holistic, patient-centered care that integrates medical, nutritional, and emotional support. Since its founding in 2020, the company has experienced rapid growth, expanding its patient base fivefold and partnering with major insurers to cover approximately 30 million lives across multiple states[1][2][3][5].
Allara was founded in 2020 by Rachel Blank, who was motivated by her own struggles to find effective, holistic care for chronic hormonal conditions. Growing up with an OB-GYN father, Blank initially assumed women’s health care was well-served but realized many women face significant gaps in diagnosis and treatment for conditions like PCOS. This personal experience inspired her to create a telehealth platform that could close these gaps by connecting women to specialized care providers virtually. Early traction included securing significant investment, such as a $10 million Series A led by Google Ventures, and forming partnerships with major health insurers and health systems to broaden access and improve care coordination[2][3][6].
Allara is riding the growing trend of virtual and hybrid healthcare delivery, particularly in the underserved niche of women’s hormonal and metabolic health. The timing is critical as awareness of conditions like PCOS and endometriosis increases, alongside broader acceptance of telemedicine accelerated by the COVID-19 pandemic. Market forces such as rising demand for personalized, accessible care and insurer willingness to cover telehealth services favor Allara’s model. By integrating specialty care into a virtual platform, Allara helps close a massive care gap, reduces the burden on traditional health systems, and sets a precedent for holistic, tech-enabled chronic care management in women’s health[1][2].
Looking ahead, Allara is poised to expand its insurance coverage and deepen partnerships with health systems and fertility groups to enhance chronic care and perioperative management virtually. Trends shaping its journey include increasing digital health adoption, growing recognition of women’s health disparities, and advances in personalized medicine. As Allara scales, it may influence broader healthcare delivery models by demonstrating the value of integrated, specialty telehealth platforms that combine medical, nutritional, and emotional care. Its continued growth and innovation could redefine how chronic hormonal and gynecological conditions are managed nationwide, fulfilling its mission to provide the compassionate, specialized care women deserve[2][3][6].
Allara has raised $36.0M across 2 funding rounds. Most recently, it raised $26.0M Series B in January 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2025 | $26.0M Series B | Addition, Forerunner Ventures, Future Positive Capital, David Krane, GV, Hardware Club, Index Ventures, Proximo Ventures, #SecretFund, True Ventures, Clement Benoit, Fanny Surjana, Harold Mechelynck, Romain Afflelou, Thibaud Elziere | |
| Oct 1, 2023 | $10.0M Series A | Forerunner Ventures, David Krane, GV, Index Ventures, True Ventures, Fanny Surjana |